Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb Co. (BMY) PT Raised to $63 at BMO Capital

April 17, 2019 6:46 AM
BMO Capital analyst Alex Arfaei raised the price target on Bristol-Myers ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst EPS View Analyst PT Change